% ================================================================
% EMPIRICAL APPLICATION — Dominick's Analgesics
% Auto-generated by dominicks_irl.py
% n\_runs = 5  (mean $\pm$ std across independent re-estimations)
% Packages: booktabs, threeparttable, graphicx, siunitx
% ================================================================

\begin{table}[htbp]
  \centering
  \caption{Descriptive Statistics: Dominick's Analgesics Scanner Panel}
  \label{tab:dom_desc}
  \begin{threeparttable}
    \begin{tabular}{lS[table-format=2.3]S[table-format=1.3]S[table-format=1.4]S[table-format=1.4]}
      \toprule
      \textbf{Good} & {\textbf{Mean Price}} & {\textbf{Std Price}} & {\textbf{Mean Share}} & {\textbf{Std Share}} \\
      & {(\$/100 tablets)} & & & \\
      \midrule
      Aspirin & 7.311 & 1.557 & 0.2107 & 0.0519 \\
      Acetaminophen & 10.554 & 1.427 & 0.5026 & 0.0785 \\
      Ibuprofen & 10.506 & 1.428 & 0.2867 & 0.0819 \\
      \midrule
      \multicolumn{5}{l}{\textit{Train: 28,644 obs\quad Test: 4,287 obs\quad Stores: 93\quad Weeks: 1--399}} \\
      \bottomrule
    \end{tabular}
    \begin{tablenotes}\small
      \item Unit prices standardised to per-100-tablet equivalent: $\hat{p}_{ij}=\text{PRICE}_{ij}\times100/\text{TABLETS}_{ij}$.
      Revenue-weighted mean across UPCs within each store$\times$week$\times$category cell.
      Aspirin: Bayer, Bufferin, Anacin, Ascriptin, Ecotrin, generics.
      Acetaminophen: Tylenol, Excedrin, Anacin-3, Panadol, Datril, Pamprin, store brands.
      Ibuprofen: Advil, Motrin~IB, Nuprin, Aleve, Actron, Orudis~KT, Haltran, Medipren.
    \end{tablenotes}
  \end{threeparttable}
\end{table}

\begin{table}[htbp]
  \centering
  \caption{Out-of-Sample Predictive Accuracy --- Dominick's Analgesics (5 independent re-estimations; mean $\pm$ std)}
  \label{tab:dom_acc}
  \begin{threeparttable}
    \begin{tabular}{lcc}
      \toprule
      \textbf{Model} & \textbf{RMSE} & \textbf{MAE} \\
      \midrule
      LA-AIDS & $0.07069 \pm 0.00000$ & $0.05593 \pm 0.00000$ \\
      BLP (IV) & $0.12147 \pm 0.00000$ & $0.09451 \pm 0.00000$ \\
      Lin IRL Shared & $0.09200 \pm 0.00000$ & $0.07360 \pm 0.00000$ \\
      Lin IRL GoodSpec & $0.09197 \pm 0.00000$ & $0.07356 \pm 0.00000$ \\
      Lin IRL Orth & $0.08716 \pm 0.00000$ & $0.07092 \pm 0.00000$ \\
      Neural IRL & $0.06461 \pm 0.00057$ & $0.05010 \pm 0.00051$ \\
      \textbf{MDP Neural IRL} & \textbf{$0.05055 \pm 0.00011$} & $0.03810 \pm 0.00014$ \\
      Var. Mixture & $0.09814 \pm 0.01540$ & $0.08245 \pm 0.01378$ \\
      \bottomrule
    \end{tabular}
    \begin{tablenotes}\small
      \item RMSE and MAE on held-out test observations, mean $\pm$ std over 5 run(s).
      MDP Neural IRL augments the state with lagged budget shares
      $\bar{x}_t=\delta\bar{x}_{t-1}+(1-\delta)w_{t-1}$ ($\delta=0.7$)
      capturing brand-loyalty inertia. Bold: best mean RMSE.
    \end{tablenotes}
  \end{threeparttable}
\end{table}

\begin{table}[htbp]
  \centering
  \caption{Own-Price Quantity Elasticities --- Dominick's Analgesics (5 run(s); mean $\pm$ std)}
  \label{tab:dom_elast}
  \begin{threeparttable}
    \begin{tabular}{lccc}
      \toprule
      \textbf{Model} & {$\hat{\varepsilon}_{00}$ (Aspirin)} & {$\hat{\varepsilon}_{11}$ (Acetaminophen)} & {$\hat{\varepsilon}_{22}$ (Ibuprofen)} \\
      \midrule
      LA-AIDS & $-0.849 \pm 0.000$ & $-1.420 \pm 0.000$ & $-1.140 \pm 0.000$ \\
      BLP (IV) & $-0.831 \pm 0.000$ & $-0.141 \pm 0.000$ & $-1.000 \pm 0.000$ \\
      Lin IRL Shared & $-0.163 \pm 0.000$ & $-0.213 \pm 0.000$ & $-0.188 \pm 0.000$ \\
      Lin IRL GoodSpec & $-0.164 \pm 0.000$ & $-0.205 \pm 0.000$ & $-0.181 \pm 0.000$ \\
      Lin IRL Orth & $-1.139 \pm 0.000$ & $-1.105 \pm 0.000$ & $-1.149 \pm 0.000$ \\
      Neural IRL & $-0.827 \pm 0.019$ & $-1.563 \pm 0.009$ & $-1.198 \pm 0.023$ \\
      MDP Neural IRL & $-0.809 \pm 0.021$ & $-1.199 \pm 0.016$ & $-1.072 \pm 0.022$ \\
      Var. Mixture & $-1.490 \pm 0.151$ & $-1.365 \pm 0.108$ & $-1.492 \pm 0.157$ \\
      \bottomrule
    \end{tabular}
    \begin{tablenotes}\small
      \item Numerical own-price quantity elasticities at mean test prices and expenditure.
      Mean $\pm$ std over 5 independent re-estimation(s).
    \end{tablenotes}
  \end{threeparttable}
\end{table}

\begin{table}[htbp]
  \centering
  \caption{Consumer Surplus Loss from 10\% Ibuprofen Price Increase --- Dominick\'s Analgesics (5 run(s); mean $\pm$ std)}
  \label{tab:dom_welfare}
  \begin{threeparttable}
    \begin{tabular}{lcr}
      \toprule
      \textbf{Model} & \textbf{CV Loss (\$)} & \textbf{vs Neural IRL} \\
      \midrule
      LA-AIDS & $-0.3487 \pm 0.0000$ & +3.7\% \\
      BLP (IV) & $-0.2807 \pm 0.0000$ & +22.5\% \\
      Lin IRL Shared & $-0.4216 \pm 0.0000$ & -16.4\% \\
      Lin IRL GoodSpec & $-0.4217 \pm 0.0000$ & -16.4\% \\
      Lin IRL Orth & $-0.3102 \pm 0.0000$ & +14.4\% \\
      Neural IRL & $-0.3623 \pm 0.0019$ &  \\
      MDP Neural IRL & $-0.4098 \pm 0.0012$ & -13.1\% \\
      Var. Mixture & $-0.3031 \pm 0.0289$ & +16.3\% \\
      \bottomrule
    \end{tabular}
    \begin{tablenotes}\small
      \item Compensating variation via 100-step Riemann sum, $p_{\mathrm{Ibu}}\to(1+0.1)\,p_{\mathrm{Ibu}}$.
      Mean $\pm$ std over 5 run(s).
    \end{tablenotes}
  \end{threeparttable}
\end{table}

\begin{table}[htbp]
  \centering
  \caption{MDP State Augmentation: Brand Loyalty in Analgesic Demand (5 run(s); mean $\pm$ std)}
  \label{tab:dom_mdp}
  \begin{threeparttable}
    \begin{tabular}{lcccc}
      \toprule
      \textbf{Model} & \textbf{RMSE} & \textbf{KL Div.} & \textbf{Reduction} \\
      \midrule
      LA-AIDS & $0.07069 \pm 0.00000$ & $0.02311 \pm 0.00000$ & baseline \\
      Neural IRL (static) & $0.06461 \pm 0.00057$ & $0.01976 \pm 0.00039$ & 8.6% \\
      \textbf{MDP Neural IRL (x̄ state)} & \textbf{$0.05055 \pm 0.00011$} & $0.01183 \pm 0.00005$ & 28.5% \\
      \bottomrule
    \end{tabular}
    \begin{tablenotes}\small
      \item $\bar{x}_t=\delta\bar{x}_{t-1}+(1-\delta)w_{t-1}$, $\delta=0.7$.
      Captures repeat-purchase inertia: aspirin loyalists (Bayer, Bufferin)
      rarely switch to ibuprofen products even under promotional pricing.
      RMSE and KL: mean $\pm$ std over 5 independent re-estimation(s).
    \end{tablenotes}
  \end{threeparttable}
\end{table}

\begin{table}[htbp]
  \centering
  \caption{Variational Mixture IRL: Consumer Segments --- Dominick\'s Analgesics ($K=6$; last of 5 run(s))}
  \label{tab:dom_mix}
  \begin{threeparttable}
    \begin{tabular}{cS[table-format=1.3]S[table-format=1.3]S[table-format=1.3]S[table-format=1.3]S[table-format=1.3]l}
      \toprule
      $k$ & {$\hat{\pi}_k$} & {$\hat{\alpha}_{\text{Asp}}$} & {$\hat{\alpha}_{\text{Acet}}$} & {$\hat{\alpha}_{\text{Ibu}}$} & {$\hat{\rho}$} & Segment \\
      \midrule
      1 & 0.073 & 0.257 & 0.360 & 0.383 & 0.301 & Balanced \\
      2 & 0.825 & 0.261 & 0.429 & 0.310 & 0.370 & \textbf{Dominant / mixed} \\
      3 & 0.029 & 0.342 & 0.295 & 0.363 & 0.420 & Balanced \\
      4 & 0.022 & 0.333 & 0.307 & 0.360 & 0.480 & Balanced \\
      5 & 0.022 & 0.336 & 0.301 & 0.364 & 0.540 & Balanced \\
      6 & 0.029 & 0.379 & 0.381 & 0.240 & 0.600 & Price-sensitive switchers \\
      \bottomrule
    \end{tabular}
    \begin{tablenotes}\small
      \item Gaussian mixture in $(\bm{\alpha},\rho)$ CES parameter space.
      Brand-loyal segments reflect documented repeat-purchase inertia in
      OTC analgesics: aspirin users (Bayer/Bufferin loyalists), Tylenol
      users, and Advil/Motrin users rarely switch across active-ingredient
      categories. Price-sensitive switchers respond to promotional pricing.
      Results shown for the last of 5 independent run(s).
    \end{tablenotes}
  \end{threeparttable}
\end{table}

\begin{figure}[htbp]
  \centering
  \includegraphics[width=\textwidth]{figures/dominicks/fig_demand_curves.pdf}
  \caption{Aspirin Budget Share as a Function of Ibuprofen Unit Price --- Dominick's Analgesics. All models trained on pre-cutoff store$\times$week observations. The orange dotted line marks the mean ibuprofen unit price in the test sample. Neural IRL (blue) and MDP-IRL (teal) trace nearly identical curves, lying above LA-AIDS at high prices --- consistent with stronger own-price sensitivity in the data. Lin IRL Shared (yellow) is flattened by promotional price collinearity, replicating the feature-collinearity finding from the simulation study. Shaded bands indicate $\pm 1$ standard deviation across 5 independent re-estimations.}
  \label{fig:dom_demand}
\end{figure}

\begin{figure}[htbp]
  \centering
  \includegraphics[width=\textwidth]{figures/dominicks/fig_mdp_advantage.pdf}
  \caption{MDP-Aware Neural IRL vs.\ Static Models --- Dominick's Analgesics (all three budget shares). The MDP Neural IRL (teal) conditions on the lagged budget share $\bar{x}_t$, capturing brand-loyalty persistence absent from static models. Differences are largest for aspirin (left panel), where Bayer and Bufferin repeat-purchase inertia is strongest. Shaded bands indicate $\pm 1$ standard deviation across 5 independent re-estimations.}
  \label{fig:dom_mdp}
\end{figure}

\begin{figure}[htbp]
  \centering
  \includegraphics[width=\textwidth]{figures/dominicks/fig_convergence.pdf}
  \caption{Training Convergence --- Dominick's Analgesics  (last run). Left: Neural IRL (static). Right: MDP Neural IRL. The learnable temperature $\hat{\beta}$ stabilises rapidly, providing a data-driven estimate of consumer rationality in the analgesics category. The MDP model's KL trajectory reflects the additional information extracted from the lagged-share state.}
  \label{fig:dom_conv}
\end{figure}

\begin{figure}[htbp]
  \centering
  \includegraphics[width=\textwidth]{figures/dominicks/fig_scatter.pdf}
  \caption{Observed vs.\ Predicted Budget Shares --- Dominick's Analgesics (3 models $\times$ 3 goods; last run). Points on the 45-degree line indicate perfect prediction. Neural IRL and MDP-IRL cluster tighter around the diagonal than LA-AIDS, consistent with the RMSE comparisons in Table~\ref{tab:dom_acc}.}
  \label{fig:dom_scatter}
\end{figure}

\begin{figure}[htbp]
  \centering
  \includegraphics[width=\textwidth]{figures/dominicks/fig_mixture.pdf}
  \caption{Continuous Variational Mixture IRL ($K=6$) --- Dominick's Analgesics  (last run). Left: recovered weights $\hat{\pi}_k$ with $\hat{\rho}$ annotated. Right: component centres in $(\hat{\alpha}_{\mathrm{Asp}},\hat{\alpha}_{\mathrm{Acet}})$ space; marker size $\propto\hat{\pi}_k$. Identified segments correspond to brand-loyal aspirin, acetaminophen, and ibuprofen users, plus a price-sensitive switching segment with high $\hat{\rho}$.}
  \label{fig:dom_mix}
\end{figure}

\begin{figure}[htbp]
  \centering
  \includegraphics[width=\textwidth]{figures/dominicks/fig_rmse_bars.pdf}
  \caption{Out-of-Sample RMSE across all models --- mean $\pm 1$ SD over 5 independent re-estimations.  Error bars quantify sensitivity to random initialisation.  Deterministic models (LA-AIDS, BLP-IV) show zero variance by construction.}
  \label{fig:dom_rmse_bars}
\end{figure}

\begin{figure}[htbp]
  \centering
  \includegraphics[width=\textwidth]{figures/dominicks/fig_beta_runs.pdf}
  \caption{Learned temperature parameter $\hat{\beta}$ across 5 independent re-estimations.  Violin plots show the full sampling distribution; means and medians are marked.  The narrow spread confirms that the rationaliy level identified by MaxEnt IRL is robust to initialisation.}
  \label{fig:dom_beta_runs}
\end{figure}
